Closed consultation: Removing zuranolone from the Prescription Drug List
Current status: Closed
This consultation ran from February 7, 2026 to April 18, 2026.
This consultation provided an opportunity to comment on the proposal to remove “zuranolone or its salts” from both the Human and Veterinary parts of the Prescription Drug List (PDL).
Who was the focus of this consultation
We engaged with:
- interested members of the public
- healthcare practitioners
- healthcare professional associations
- any other interested stakeholders
Related information
- Canada Gazette Part I
- Prescription Drug List
- Controlled Drugs and Substances Act
- Benzodiazepines and Other Targeted Substances Regulations
- Food and Drugs Act
Contact us
Office of Legislative and Regulatory Affairs
Controlled Substances and Overdose Response Directorate
Health Canada
Email: csd.regulatory.policy-politique.reglementaire.dsc@hc-sc.gc.ca